Skip to content
Study details
Enrolling now

Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Ohio State University Comprehensive Cancer Center
NCT IDNCT04427566ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

24

Study length

about 1.4 years

Ages

18+

Locations

1 site in OH

What this study is about

This trial is testing whether low doses of radiation therapy to the lungs can reduce inflammation in people with COVID-19 who are having trouble breathing. The treatment uses X-ray beams from a machine to target the lungs and lessen inflammation, potentially helping patients breathe without needing a ventilator.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Radiation therapy

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Change in performance status after low dose radiation to lungs, Incidence of adverse events, including severity and duration, for administration of low dose radiation to lungs

Procedures

radiation

Body systems

Infectious